Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
05 10월 2023 - 9:30PM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader
in life science research and clinical diagnostics products, will
report its financial results for the third quarter of 2023 on
Thursday, October 26, 2023, following the close of the market.
Management will discuss these results in a conference call
scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
To participate, call 888-259-6580 within the U.S., or (+1)
206-962-3782 from outside the U.S., and provide access code:
65942913.
A live webcast of the conference call will also be available in
the "Investor Relations" section of the company’s website under
"Events & Presentations" at investors.bio-rad.com. A replay of
the webcast will be available for up to a year.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a leader in
developing, manufacturing, and marketing a broad range of products
for the life science research and clinical diagnostics markets.
Based in Hercules, California, Bio-Rad operates a global network of
research, development, manufacturing, and sales operations with
over 8,200 employees and $2.8 billion in revenues in 2022. Our
customers include universities, research institutions, hospitals,
food safety and environmental quality laboratories, and
biopharmaceutical companies. Together, we develop innovative,
high-quality products that advance science and save lives. To learn
more, visit bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231005466163/en/
Investor Contact: Edward Chung, Investor Relations
510-741-6104 ir@bio-rad.com
Media Contact: Anna Gralinska, Corporate Communications
510-741-6643 pr@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Bio Rad Laboratories (NYSE:BIO)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024